We would love to hear your thoughts about our site and services, please take our survey here.
What can we expect from today's investor day? I'm still optimistic inspite of everything which has been thrown at us these past several weeks!
Plotting NAV against results dates (published in various RNSs over the past 5 years) is impressive. The latest update (last week) suggests the upward trend continues; and the next published NAV is likely to be ~ 1000p/s. So the shares are currently trading at a *discount* of 20% or more. Yet to me at least the steady progress over the past 5 years would suggest a premium was justified. Why might the market believe otherwise! What am I missing?
I add my glad tidings to all, most especially to our two major BB contributors, W3Ken and steph. The year has seen my rule-of-thumb broken, that no share should constitute more than 15% of my portfolio. GROW is now double that, following 7 purchases {and no sales) in the year at prices ranging 763 to 1037 (6 of 7 showing gains). Trading on behalf of other family members the 2021 record is similar. And whereas I view my TESLA holding with a little anxiety I think of GROW as rock solid (well, almost).
With the share price at, or even below, the NAV/share, it's a no-brainer: time to top-up.
I arrived here hoping to see comments on Easyjet; and all I got was Covid-related agro. Sadly, goodbye.
and yet .... both yesterday, when sp up 4%, and this morning, down 7%, more shares bought than sold. All very puzzling; and somewhat stressful. Better perhaps to stop looking!
Steph, I feel the need to acknowledge your contributions to this BB! And though my optimism for GROW’s sp hasn’t quite matched yours I’ve not once doubted the long term prospects. That, at least in part, is thanks to your reports. It’s been a frustrating few weeks since the 1180p peak in early September when my portfolio, heavily weighted in favour of GROW, reached an all-time high. Since then other family members have been hitting new ATHs, especially those into Tesla, but now it’s my turn again. My thoughts on today’s RNS are that I had expected/hoped-for, something even a bit better. As you might say, there’s probably still some reserves in the tank; and clearly ‘the market’ is impressed.
In the rankings at end of October 2021 DARK was 88th with sp = 802.5p. If by end of November all other shares were to remain unchanged a share price of 617p would cause DARK to drop to 111th which would imply automatic relegation to the FTSE(250).
Recent wise words are not to be denied! Now, for me the two fundamental questions are 1). is this share a good long-term prospect; with confidence ‘yes’, when looking at say a 3-year horizon: and 2). is now a good time for further buys; not so easy, but combining the principles of ‘pound-cost averaging’ with ‘buying the dip’, I’ve decided to add some more (@977p).
Before 7am? Very possible!
Yes, the shares have gone ex-div at start of trading today. The divi is 21.9p/share so current sp movement (down 14.4p) is equivalent to a 7.5p rise [which is just less than 1%, about the same as the move in Persimmon this morning, for example].
My top-up yesterday was the second within a few days. Whether it's U or V or any other shape this still looks to be a great long-term bet: and as with 'Sage', I too have invested on behalf of the next generation.
Not for the first time I followed you Steph with a top-up. I believe that's my 19th purchase since the first almost two years ago.
Results seemed good-ish to me, yet sp 3% down. Perverse? Anyway, topped up.
Sp = 174p; NAV (Jun 2021) = 242p/s; discount = 28%. Seems unduly pessimistic, any thoughts as to why?
The recent sp rise has forced me to consider rebalancing my portfolio. Having already, earlier this year, revised my rule-of-thumb and raised the limit for any single investment [from 15% to 20% of portfolio], the choice was to either off-load some GROW shares or to raise that limit again. Limit raised!
Thankd Ken, it makes such good reading (to a shareholder especially).
I've seen much optimism on this board based on the belief that AffiDX offers the best lateral flow test. But *who* is it that says it is the best? I'm unconvinced at this stage because if it was the best surely AVACTA would be making commercial strides.
When
So familiar: too much emphasis on what is planned, too little on what has been achieved. Yet I believe the potential is still their so it's a case of "be patient"!